Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osaka Gakuin University
InstitutionResearch output, impact & collaborations
Osaka Gakuin University is a research organisation in Suita, JP. OpenAlex records 4,025 works and 171,511 citations for it. 2,017 researchers list it as their most recent affiliation.
4,025
Works
171,511
Citations
2,017
Researchers
63.7
Avg h-index
How has Osaka Gakuin University's publication output changed over time?
ScholarIQpublication output · 1990–2022
Output grew0% over the shown period — from 1 works in 1990 to 1 in 2022.
1
1
1
1
1
1
2
2
1
1
1990200520072011201220132016201920212022
Who are the most-cited researchers behind Osaka Gakuin University?
ScholarIQtop researchers by citations
What are the most-cited papers on Osaka Gakuin University?
ScholarIQmost cited works
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
Biykem Bozkurt, Andrew J.S. Coats, Hiroyuki Tsutsui, Magdy Abdelhamid, Stamatis Adamopoulos, Nancy M. Albert, Stefan D. Anker, J. Atherton, Michael Böhm, Javed Butler, Mark H. Drazner, G. Michael Felker, Gerasimos Filippatos, Mona Fiuzat, Gregg C. Fonarow, Juan‐Esteban Gomez‐Mesa, Paul A. Heidenreich, Teruhiko Imamura, Ewa A. Jankowska, James L. Januzzi, Prateeti Khazanie, Koichiro Kinugawa, Carolyn S.P. Lam, Yuya Matsue, Marco Metra, Tomohito Ohtani, Massimo Piepoli, Piotr Ponikowski, Giuseppe Rosano, Yasushi Sakata, Petar Seferović, Randall C. Starling, John R. Teerlink, Orly Vardeny, Kazuhiro Yamamoto, Clyde W. Yancy, Jian Zhang, Shelley Zieroth
European Journal of Heart Failure. 20211,598 CitationsOPEN ACCESS
Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source
Yusuke Sakaguchi, Ichiro Sekiya, Kazuyoshi Yagishita, Takeshi Muneta
S132787887. 20051,553 Citations
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chìn, Shigenori Kadowaki, Myung‐Ju Ahn, Yasuo Hamamoto, Yuichiro� Doki, Chueh‐Chuan Yen, Yutaro Kubota, Sung‐Bae Kim, Chih‐Hung Hsu, Eva Holtved, Ioannis Xynos, Mamoru Kodani, Yuko Kitagawa
The Lancet Oncology. 20191,250 CitationsOPEN ACCESS
CEREBRAL BLOOD FLOW, BLOOD VOLUME AND OXYGEN UTILIZATION
Klaus L. Leenders, Daniela Perani, Adriaan A. Lammertsma, J. D. Heather, P. D. Buckingham, T. JONES, M. J. R. Healy, J. M. Gibbs, Richard G. Wise, Jun Hatazawa, S. Herold, R. P. BEANEY, D. J. BROOKS, T. SPINKS, C. RHODES, R. S. J. FRACKOWIAK
Brain. 19901,107 Citations
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink, Sean P. Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E. Nassif, Mitchell A. Psotka, Jasper Tromp, C. Jan Willem Borleffs, Changsheng Ma, J COMINCOLET, Michael Fu, Stefan Janssens, Róbert Gábor Kiss, Robert J. Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P. Christian Schulze, Lenka Špinarová, Maurizio Volterrani, Jerzy Krzysztof Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jon Blatchford, Afshin Salsali, Piotr Ponikowski
Nature Medicine. 2022916 CitationsOPEN ACCESS
How much of the research on Osaka Gakuin University is open access?
ScholarIQopen access share
50%OPEN ACCESS
Gold
8%
Green
8%
Hybrid
8%
Bronze
25%
Closed
50%